Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
AFT Pharmaceuticals (AFT NZ)
Watchlist
60
Analysis
Health Care
•
New Zealand
AFT Pharmaceuticals Limited develops, licenses, and sells pharmaceutical products. The Company offers medicines for allergy, cough, cold, and flu, eye care, pain management, and laxatives. AFT Pharmaceuticals serves customers worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
AFT Pharmaceuticals
•
25 Nov 2021 08:36
•
Broker
AFT Pharmaceuticals (AFT): 1H22 Result – Initial Impressions
AFT Pharmaceuticals (AFT)1H22 Result – Initial Impressions AFT Pharmaceuticals (AFT) reported a 1H22 result below expectations, but significantly...
Forsyth Barr
Follow
912 Views
Share
bullish
•
Aft Pharmaceuticals
•
22 Nov 2021 21:34
•
Issuer-paid
AFT Pharmaceuticals - 14% revenue growth despite COVID-19 headwinds
AFT Pharmaceuticals recently reported its results for H122. Operating revenue grew strongly by 14% year-on-year to NZ$55.5m, despite the impact of...
Edison Investment Research
Follow
832 Views
Share
bullish
•
Fisher & Paykel Healthcare Corp
•
20 Oct 2021 08:05
•
Broker
Company Coverage: Temporary Analyst Change
Company Coverage Temporary Analyst Change We temporarily transfer coverage of the following companies to Matt Montgomerie due to...
Forsyth Barr
Follow
404 Views
Share
bullish
•
AFT Pharmaceuticals
•
31 May 2021 08:10
•
Broker
AFT Pharmaceuticals: FY21 Result — Pain Relieving
AFT PharmaceuticalsFY21 Result — Pain Relieving RESEARCH INSIGHTS AFT Pharmaceuticals (AFT) reported an FY21 result at the upper-end of its...
Forsyth Barr
Follow
702 Views
Share
bullish
•
AFT Pharmaceuticals
•
26 May 2021 14:36
•
Issuer-paid
AFT Pharmaceuticals - Growth in the face of a challenging environment
AFT Pharmaceuticals recently reported its results for FY21. Operating revenue grew strongly by 7% year-on-year to NZ$113.1m, driven mainly by 11%...
Edison Investment Research
Follow
623 Views
Share
First
Previous
4
5
6
7
8
9
10
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x